Crispr has been demonstrates to act at cancer causing mutation locations. Target selection is vital to success and require targeting multiple different mutations simultaneously.

Bad targeting has been rare and inconsequential in the context of current treatment side effects i.e. chemo and radiation.

Crispr can by used more than once to mop ip stragglers.